Align Technology, Inc. (0HCK.L)
USD 148.11
(-3.24%)
USD 148.11
(-3.24%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 96.96 Million USD | -3.35% |
| 2022 | 100.33 Million USD | -2.26% |
| 2021 | 102.65 Million USD | 59.29% |
| 2020 | 64.44 Million USD | 48.28% |
| 2019 | 43.46 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 95.09 Million USD | 0.0% |
| 2024 Q3 | - USD | 0.0% |
| 2024 Q2 | 98.3 Million USD | 0.0% |
| 2023 Q2 | 104.65 Million USD | 5.7% |
| 2023 Q1 | 99 Million USD | -1.33% |
| 2023 FY | 96.96 Million USD | -3.35% |
| 2023 Q4 | 96.96 Million USD | -1.58% |
| 2023 Q3 | 98.52 Million USD | -5.85% |
| 2022 Q3 | 96.69 Million USD | -1.67% |
| 2022 Q2 | 98.33 Million USD | -6.34% |
| 2022 Q1 | 104.98 Million USD | 2.27% |
| 2022 FY | 100.33 Million USD | -2.26% |
| 2022 Q4 | 100.33 Million USD | 3.76% |
| 2021 Q1 | 63.84 Million USD | -0.93% |
| 2021 FY | 102.65 Million USD | 59.29% |
| 2021 Q4 | 102.65 Million USD | 38.07% |
| 2021 Q3 | 74.35 Million USD | 0.23% |
| 2021 Q2 | 74.18 Million USD | 16.19% |
| 2020 Q4 | 64.44 Million USD | -1.64% |
| 2020 Q1 | 53.74 Million USD | 23.66% |
| 2020 Q3 | 65.51 Million USD | 29.43% |
| 2020 Q2 | 50.61 Million USD | -5.82% |
| 2020 FY | 64.44 Million USD | 48.28% |
| 2019 Q1 | 59.3 Million USD | 0.0% |
| 2019 FY | 43.46 Million USD | 0.0% |
| 2019 Q4 | 43.46 Million USD | 0.23% |
| 2019 Q3 | 43.36 Million USD | -26.67% |
| 2019 Q2 | 59.14 Million USD | -0.28% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -4632.455% |
| Accuray Incorporated | 164.4 Million USD | 41.017% |
| Elevance Health Inc. | 23.24 Billion USD | 99.583% |
| AxoGen, Inc. | 46.6 Million USD | -108.072% |
| Boston Scientific Corporation | 8.56 Billion USD | 98.868% |
| CVS Health Corporation | 74.67 Billion USD | 99.87% |
| Cardinal Health, Inc. | 4.58 Billion USD | 97.884% |
| Centene Corporation | 17.69 Billion USD | 99.452% |
| DaVita Inc. | 8.05 Billion USD | 98.796% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 99.735% |
| Hologic, Inc. | 2.49 Billion USD | 96.117% |
| Humana Inc. | 10.21 Billion USD | 99.051% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 84.432% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 97.609% |
| Masimo Corporation | 871.7 Million USD | 88.876% |
| McKesson Corporation | 5.45 Billion USD | 98.221% |
| Patterson Companies, Inc. | 328.91 Million USD | 70.518% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 97.801% |
| ResMed Inc. | 697.31 Million USD | 86.094% |
| Henry Schein, Inc. | 1.93 Billion USD | 94.984% |
| Teladoc Health, Inc. | 1.58 Billion USD | 93.869% |
| Universal Health Services, Inc. | 4.71 Billion USD | 97.944% |
| Veeva Systems Inc. | 46.44 Million USD | -108.798% |
| Baxter International Inc. | 11.06 Billion USD | 99.124% |
| Becton, Dickinson and Company | 14.73 Billion USD | 99.342% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 218.11% |
| Danaher Corporation | 17.66 Billion USD | 99.451% |
| Stryker Corporation | 10.9 Billion USD | 99.11% |
| Medtronic plc | 23.87 Billion USD | 99.594% |